GSK cautious on 2018, as drug competition looms, after Q4 beats

GlaxoSmithKline said its earnings could slip this year, after a better-than-expected performance in the fourth quarter.
Source: CNBC

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>